Roche introduces Ventana HER2 Dual ISH assay

Roche’s new assay is designed to identify the HER2 biomarker in breast and gastric cancers. Credit: F. Hoffmann-La Roche Ltd.



  • Roche introduces Ventana HER2 Dual ISH assay